NEW YORK, NY — TG Therapeutics, Inc. (NASDAQ: TGTX), announced that it has been awarded a national contract with the Department of Veterans Affairs (VA) for BRIUMVI® (ublituximab-xiiy) to be the preferred agent listed on the VA National Formulary for Anti-CD20 Antibody indications for patients with relapsing forms of multiple sclerosis...
Latest News
NEW YORK, – TG Therapeutics, Inc. (NASDAQ: TGTX), announced the completion of the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) requesting approval of ublituximab, the Company’s investigational glycoengineered anti-CD20 monoclonal antibody, in combination with UKONIQTM (umbralisib) , the Company’s once-daily, oral, inhibitor...
THE WOODLANDS, Texas — Ollie Rasberry has Metachromatic leukodystrophy (MLD), a rare and fatal disease. His big sister, Addi, has it, too. She is 5 years old, and the disease has already progressed rapidly in her. Life expectancy for a child living with their form of MLD is between 5...
San Francisco, Calif. – University of California San Francisco scientists have found a way to predict Alzheimer’s Disease up to seven years before symptoms appear by analyzing patient records with machine learning. The conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, the bone-weakening disease osteoporosis....
BRIDGEWATER, NJ – Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology announced today the first patient dosed in the Company’s Phase 1 clinical trial with TH104, utilizing a proprietary oral thin film. TH104 is a proprietary transmucosal buccal film embedded with...
The slightest touch of a butterfly’s wing can cause significant long-term damage. For many with a rare skin disease called epidermolysis bullosa, their skin carries a similar fate. Holding a newborn to console its cries. Taking a child by the hands and swinging it around. Sliding down a waterslide on...
LOS ANGELES – 54 honorees representing 23 states participated in the 2022 Donate Life Rose Parade® float, “Courage to Hope.” With ages ranging from 16 to 71 years old for riders and walkers, and from 9 days old, to 55 years old for floragraph honorees, these participants and their families...
BRONX NY — Neurologists often diagnose Alzheimer’s disease after evaluating patients during lengthy, in-person office visits. This poses a significant challenge for many groups, particularly people with limited access to specialized care, including people from historically marginalized groups and people living in rural areas. Albert Einstein College of Medicine has...
SAN DIEGO, Calif. – Of the 46 cancer drugs that the U.S. Food and Drug Administration (FDA) granted accelerated approval between 2013-2017, 63% were converted to regular approval even though only 43% demonstrated a clinical benefit in confirmatory trials after more than five years of follow-up, according to a study...
CHICAGO, Illinois – The American Society for Transplantation and Cellular Therapy® (ASTCT®) supports the decision by the U.S. Food and Drug Administration’s (FDA) to grant multiple myeloma patients earlier access to CAR T-cell therapy Abecma as a second-line treatment and the CAR T therapy Carvykti as a third-line treatment. The...